Genitourinary Cancer in 2020 and Beyond

Expert perspectives and strategic insights on the latest therapeutic developments and translational research in genitourinary cancer treatment. Topics include clinical decision making and the the extent to which emerging data will affect ongoing research, development of new compounds, and future treatment paradigms.

December 8 & 9, 2020
Daniel Petrylak, MD, Yale, Aptitude Health


Daniel Petrylak, MD

Yale University, CT, US

Faculty Members

Emmanuel Antonarakis, MBBCh
Johns Hopkins University, Baltimore, MD, US

David Nanus, MD
Weill Cornell Medicine, New York, NY, US

Oliver Sartor, MD
Tulane University School of Medicine, New Orleans, LA, US

Susan Slovin, MD, PhD, FACP
Memorial Sloan Kettering Cancer Center, New York, NY, US

Leonard Gomella, MD, FACS
Thomas Jefferson University, Philadelphia, PA, US

Scott Tagawa, MD
Weill Cornell Medicine, New York, NY, US

Neeraj Agarwal, MD
Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, UT, US

Sample Report

Start discovering the insights

View Report


The report that will be produced on the basis of the meeting will discuss the following topics

  • Novel Imaging Strategies for Genitourinary Cancers
  • New Strategies for Metastatic RCC
  • Current and Future Management of Non-clear Cell RCC
  • Neo/Adjuvant Treatment of RCC
  • Techniques for Detection and Treatment of Localized/Locally Advanced Prostate Cancer
  • Treatment Paradigms for Advanced Prostate Cancer
  • Emerging Therapies for Metastatic CRPC
  • Early Stage Bladder Cancer
  • Current and Future Treatment of Advanced Bladder Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.